Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase III pivotal trial of PIKA rabies vaccine

Trial Profile

A Phase III pivotal trial of PIKA rabies vaccine

Phase of Trial: Phase III

Latest Information Update: 15 Oct 2018

At a glance

  • Drugs Rabies vaccine Yisheng Biopharma (Primary)
  • Indications Rabies
  • Focus Pharmacodynamics; Registrational
  • Sponsors Yisheng Biopharma
  • Most Recent Events

    • 15 Oct 2018 New trial record
    • 08 Oct 2018 According to a Yisheng Biopharma media release, the China Food and Drug Administration (CFDA) has provided clearance to proceed with this clinical trial.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top